Viking Therapeutics Inc.

NASDAQ: VKTX · Real-Time Price · USD
40.04
-0.20 (-0.50%)
At close: Aug 15, 2025, 3:59 PM
40.02
-0.05%
After-hours: Aug 15, 2025, 04:11 PM EDT

Viking Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-109.96M -85.89M -68.87M -54.99M
Depreciation & Amortization
-17.17M 292K 291K 296K
Stock-Based Compensation
29.71M 16.75M 8.67M 6.1M
Other Working Capital
5.86M 4.25M 3.1M -383K
Other Non-Cash Items
272K -8.07M 1.32M 29K
Deferred Income Tax
n/a n/a n/a 3.91M
Change in Working Capital
9.36M 3.55M 10.19M -2.93M
Operating Cash Flow
-87.79M -73.38M -48.4M -47.59M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-1.11B -478.3M -121.43M -168.01M
Sales Maturities Of Investments
561.2M 299.22M 176.18M 205.97M
Other Investing Acitivies
-1.2M n/a 54.75K 37.96K
Investing Cash Flow
-553.37M -179.09M 54.75M 37.96M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -7.12M -6.79M -707
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
15.37M 271.38M 12.49M 6.88M
Financial Cash Flow
612.46M 271.38M 4.16M 6.88M
Net Cash Flow
-28.84M 18.88M 10.26M -2.75M
Free Cash Flow
-87.79M -73.38M -48.4M -47.59M